Meet Naaheed Mukadam, who connected South Asian community members with her dementia research through a ‘Music, Meaning and Memory’ event.
Meet researchers in Belfast who hope that understanding changes in the eye could improve Alzheimer’s diagnosis and more.
Meet Professor Amrit Mudher, whose research uses fruit flies to understand how tau protein changes in Alzheimer’s.
Read about our position on dementia research and the changes we want to see around recruitment, funding and support.
Donanemab is currently in the headlines as a drug that appears to slow down memory and thinking decline in people living with early-stage Alzheimer’s disease. Here's what we know so far about this Alzheimer's drug.
Meet Pietro Esposito, PhD student at the University of St Andrews, who discusses his research into Alzheimer's.
Meet Geoff Parker, Professor of Healthcare Engineering, Imaging and Enterprise at UCL in London, who discusses his dementia research.
We are delighted to announce that Carol and Stuart Jennings have become Vice-Presidents of Alzheimer’s Society. The couple have contributed a vast amount to the field of dementia research, and here we share some of their incredible achievements.
Meet Kieren Egan, Senior Research Fellow at the University of Strathclyde.
Phase III trial results revealed at Clinical Trials on Alzheimer's Disease conference in San Francisco.
Meet Joe Morgan, PhD student at the University of Salford.
Meet Esra Hassan, PhD student at Brighton and Sussex Medical School’s Centre for Dementia Studies.
Yesterday (27 September 2022), Eisai Co. Ltd. and Biogen announced top-line results for a major trial on the drug lecanemab in slowing down the progress of Alzheimer’s disease. Alzheimer's Society comments on this Alzheimer’s progression drug hope.